Guest blog: Patents in the biopesticide industry revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Guest blog: Patents in the biopesticide industry revealed

Who is applying for patents in the biopesticide industry? Rubal Walia of INDUS TechInnovations explains

Although synthetic chemical fertilizers occupy a large share of pesticide market, biopesticides are gradually gaining significance. We have been looking at the patent landscape as well as the trends and patterns emerging in the Biopesticide industry.

We studied the patent filings in this technology area to understand the investments and patenting efforts being made. The infographic below outlines some interesting trends such as the pace of progress over the last decade, the geographical distribution of patents, patent transactions between different organisations and top patent asset holders.

The report displays a steady increase in published patents over the years, with 2012 revealing a sharp rise. Geographically, the US and China have dominated this area in patents and applications, followed by Europe. In addition, Monsanto, one of the pioneers in developing genetically modified seeds, leads the race as the top patent asset holder, with more than 1,400 patents. Pioneer, a Dupont company, is close behind with more than 1,000 patents.

The report also indicates that Monsanto is among the top acquirers of patents, buying patents from companies such as D&PL Technologies, Pharmacia, and Ecogen. Rivals Bayer and Gibraltar Business Capital have also acquired a large number of patents. You can see more information in the graphic.

Image The infographic was produced by Relecura, a patent and portfolio analysis platform developed by INDUS TechInnovations.

more from across site and SHARED ros bottom lb

More from across our site

Nick Aries and Elizabeth Louca at Bird & Bird unpick the legal questions raised by a very public social media spat concerning the ‘Brooklyn Beckham’ trademark
Michael Conway, who joined Birketts after nearly two decades at an IP boutique, says he was intrigued by the challenge of joining a general practice firm
The private-equity-backed firm said hires from DLA Piper and Eversheds Sutherland will help it become the IP partner of choice for innovative businesses
The acquisition is expected to help Clorox bolster its position in the health and hygiene consumer products market
AIPPI, which has faced boycott threats over the 2027 World Congress, says it has a long-standing commitment to engagement and geographic rotation
The shortlist for our annual Americas Awards will be published next month, with potential winners in more than 90 categories set to be revealed
News of Nokia signing a licensing deal with a Chinese automaker and Linklaters appointing a new head of tech and IP were also among the top talking points
After five IP partners left the firm for White & Case, the IP market could yet see more laterals
The court plans to introduce a system for expert-led SEP mediation, intended to help parties come to an agreement within three sessions
Paul Chapman and Robert Lind, who are retiring from Marks & Clerk after 30-year careers, discuss workplace loyalty, client care, and why we should be optimistic but cautious about AI
Gift this article